The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
about
The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of JanusGenomic profiling of breast cancersSystematic discovery of novel eukaryotic transcriptional regulators using sequence homology independent predictionA novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastomaTracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.miR-31 and miR-17-5p levels change during transformation of follicular lymphomaRecruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinomaThe EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1.Function and regulation of microRNA-31 in development and disease.EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway.JARID1 Histone Demethylases: Emerging Targets in Cancer.MicroRNAs and cancer: Key paradigms in molecular therapy.Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
P2860
Q26740184-302962C3-24D5-4ED8-A6E5-8CFE5EAE6712Q27013013-66C9DA5A-0B6E-4B42-83CB-EE545B1D42F9Q33837744-4900740A-4078-48AD-BB1C-477FCCF1B8D5Q35599434-8295DA4B-73BA-4CB5-AD9B-A55156C6FB99Q35930608-0CCB407D-BFEC-4442-B004-BA55E2A2890FQ36232178-71E76B59-D0EC-429B-9783-0F7271761292Q36319389-735FBD8F-F912-4A39-AF47-B887C4FBF3FAQ36544024-3D723984-AC2D-4415-A355-F65563EA4646Q36719087-FF4F8234-C956-44FA-ABA1-973EB64CD003Q36754984-58895978-18D9-40C0-B702-780E7D2F7419Q37527769-7FE2A186-D0A3-4B55-8FFD-A5375F2314B1Q38289381-CD30E21C-E316-42CD-A58A-B74C940AA66EQ38705662-33B6CA36-85A1-46C9-BA51-05375DC55EBAQ38893973-81DBED3B-9DE7-453D-A80B-58141B26CA55Q40581699-F3C2B5F2-9E08-4887-A630-CC428A6E6BA2Q40581942-8D104C3A-4F7E-4A1D-81B2-D2FE10696B05Q41111172-6DFB5392-8E5A-4F24-B067-0844EBF01703Q47123705-81E38074-2169-477C-B2C6-90F96214B14CQ47730101-978B5532-8BD2-4F42-AB95-93F4AE8AEE99Q49424922-9C5F837E-B00B-41D9-82FC-F98485661A96Q55085143-DF975C64-AD63-4DC5-8E66-528586242183
P2860
The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@en
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@nl
type
label
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@en
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@nl
prefLabel
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@en
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@nl
P2093
P2860
P50
P1433
P1476
The breast cancer oncogene EMS ...... ntimetastatic microRNA miR-31.
@en
P2093
Alberto Villanueva
August Vidal
Isaia Barbieri
Samuel Aparicio
Samuel Robson
P2860
P304
P356
10.1016/J.MOLCEL.2014.01.029
P577
2014-02-27T00:00:00Z